Suzanne Foster

Chief Executive Officer at AdaptHealth

Since May 20, 2024

Age

54 years

Education

Holds a Master of Public Health (MPH) in Law and Health Policy from Harvard University and a Juris Doctor (JD) from Suffolk University Law School.

Tenure

Joined AHCO as the Chief Executive Officer on May 20, 2024, simultaneously assuming a seat on the Board of Directors, following a distinguished career in healthcare leadership.

Also at AdaptHealth

Richard Barasch

Chairman of the Board

Albert Prast

Chief Technology Officer

Christine Archbold

Chief Accounting Officer

About

Suzanne Foster is a 54-year-old executive with over 25 years of experience in the healthcare industry, renowned for her purpose-driven leadership and commitment to improving patient outcomes.

She assumed the role of Chief Executive Officer at AHCO on May 20, 2024, and concurrently joined the Board of Directors, marking a significant milestone in her already impressive career. Her leadership journey spans prominent roles at major healthcare companies such as Beckman Coulter Life Sciences at Danaher Corporation, Cardinal Health, Stanley Healthcare, and Medtronic Advanced Energy.

Beyond her executive duties at AHCO, she has contributed extensively to the healthcare community through board memberships in notable organizations like the University System of New Hampshire and Unitil Corp., further leveraging her expertise to drive strategic growth and innovation.

$AHCO Performance Under Suzanne Foster

Past Roles

Organization	Role	Date Range	Details
Danaher Corporation	President, Beckman Coulter Life Sciences	2022 – May 20, 2024	Ended upon appointment as AHCO CEO
Cardinal Health	President, At Home Solutions	January 2020 – April 2022
Stanley Healthcare (Stanley Black & Decker)	President, Stanley Healthcare	April 2018 – January 2020	Healthcare technology operating division
University System of New Hampshire	Board of Trustees	2017 – N/A
Medtronic Advanced Energy	General Manager	August 2011 – March 2018
Salient Surgical Technologies	Vice President, Global Business Operations	N/A	Later acquired by Medtronic
Elliot Health System	Vice President, Legal & Compliance	N/A
Holland & Knight	Attorney	N/A
Wiggin & Nourie	Attorney	N/A

External Roles

Organization	Role	Date Range
Unitil Corp. (NYSE: UTL)	Board Member	2019 – Present
Multiple Private Medical Technology Companies	Board Member	N/A

Fixed Compensation

Data from FY 2024

Component Name	Amount	Payment Schedule	Additional Details
Annual Base Salary	$900,000	Annually	As outlined in the employment agreement

Performance Compensation

Data from FY 2024

Annual Incentive Bonus

Metric	Value
Target Bonus Amount	$1,080,000 (120% of the base salary of $900,000)
Bonus Payout Range	0% to 200% of the target bonus
Performance Objectives	Annual company and individual performance objectives
Evaluation Period	Fiscal Year 2024

Sign-On Inducement RSUs

Metric	Value
Grant Date	May 20, 2024
Grant Value	$4,900,000
Vesting Schedule	50% time-vested in equal annual installments over three years; 50% performance-vested at the third anniversary
Performance Metric	Total Shareholder Return (TSR) relative to peer companies
Performance Thresholds and Targets	<25th Percentile: 0%; 25th Percentile: 50%; 50th Percentile: 100%; 75th or above: 200% vesting
Share Price Determination	Based on the 20-trading day volume-weighted average price prior to the public announcement

Make-Whole Inducement RSUs

Metric	Value
Grant Date	May 20, 2024
Grant Value	$1,000,000
Vesting Schedule	Equal annual installments over two years
Performance Metric	None (time-based vesting only)
Share Price Determination	Based on the 20-trading day volume-weighted average price prior to the public announcement

Note: The above tables represent the performance compensation elements available for 2024 based solely on the provided information.